Wendy M. Smith

Familial Peripheral Keratopathy Without PAX6 Mutation

A. Sturm, S. M. Tanner, T. Mauger, 2012, Cornea.

Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases

S. Cannistra, C. Eng, T. Prior, 2001, Human Genetics.

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

B. Spiegelman, L. Aaltonen, C. Eng, 1999 .

APC-dependent suppression of colon carcinogenesis by PPARγ

B. Spiegelman, R. Kucherlapati, R. Bronson, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Over-representation of PPARγ sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population

C. Plass, A. von Deimling, C. Eng, 2000, Journal of medical genetics.

Germ-line mutations in nonsyndromic pheochromocytoma.

J. Schipper, K. Zerres, C. Eng, 2002, The New England journal of medicine.

Splenic rupture: a rare presentation of pancreatic carcinoma.

W. Frankel, Wendy M. Smith, J. Lucas, 2009, Archives of pathology & laboratory medicine.

PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.

C Eng, J L Brown, C. Eng, 2001, Human molecular genetics.

PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.

C. Eng, P. Dahia, J. Lees, 1999, Cancer research.